Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0018799 (heart disease)
 34,133 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The hypothalamic-pituitary-adrenal axis is activated in response to stress. One of the activated hypothalamic hormones is arginine vasopressin, a hormone involved in hemodynamics and osmoregulation. Copeptin, the C-terminal part of the arginine vasopressin precursor peptide, is a sensitive and stable surrogate marker for arginine vasopressin release. Measurement of copeptin levels has been shown to be useful in a variety of clinical scenarios, particularly as a prognostic marker in patients with acute diseases such as lower respiratory tract infection, heart disease and stroke. The measurement of copeptin levels may provide crucial information for risk stratification in a variety of clinical situations. As such, the emergency department appears to be the ideal setting for its potential use. This review summarizes the recent progress towards determining the prognostic and diagnostic value of copeptin in the emergency department.
 ...
PMID:The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. 2226 20

The introduction of biochemical biomarkers in the evaluation of patients with cardiovascular disease has led to practice-changing advancements in the way these patients are diagnosed and managed. Measurements of cardiac troponins or brain-type natriuretic peptide (BNP) and its precursor, N-terminal brain-type natriuretic peptide (NT-proBNP), have become indispensable in the evaluation of patients with acute coronary syndromes and heart failure, respectively, constituting an integral part of the diagnostic algorithm and risk stratification of these conditions. Copeptin, a glycopeptide, part of the prehormone molecule of the antidiuretic hormone - or arginine-vasopressin - has shown considerable promise in this field. There is evidence that copeptin might be useful as a diagnostic or prognostic biomarker and risk-stratifier in a range of cardiovascular disease conditions. The main clinical scenarios where copeptin has been studied as a biomarker are: early rule-out of myocardial infarction in patients with acute chest pain, diagnosis of heart failure in patients with acute dyspnea and determining the prognosis of destabilized or chronic stable heart failure. The present review is aimed at providing concise information about the molecular structure and biosynthesis of copeptin, the available medical chemistry methods of quantification, and the potential clinical uses of this molecule in patients with heart disease.
 ...
PMID:Copeptin as a biomarker in cardiac disease. 2347 80

Abstract Coronary congestion is a heart disease that puts many lives at risk each year. The task of coronary arteries is to distribute blood to the heart tissue and any blockage in them can cause the tissue to absorb less oxygen and nutrients than needed (ischaemia disease). This imbalance will continue until the first cell is destroyed (myocardial infarction). Simulating the myocardial infarction in the laboratory rats, this study tries to determine the extent of tissue damage through the electrocardiogram (ECG) and atrial blood pressure (ABP) synchronic signals. The signals of 50 wistar rats with a weight range of 200-300 g were recorded at 30 min in the normal case and 30 min in the ischaemia and myocardial infarction (MI) case (the artificial complete blockage was in the left anterior descending coronary artery (LAD)). For a different injury in the rats' heart, the vasopressin (AVP) with different doses was injected to 40 rats. After that the images of the heart sections and the data were extracted, the 50-dimensional feature vector was generated by using the wavelet packet transform (WPT) on the ECG and ABP signals and also by obtaining the entropy of the wavelet coefficients. The extent of tissue damage on the images of the heart tissue was extracted by using the image processing method. Finally, the amount of the damaged tissue was estimated by four artificial neural networks (ANN) (with different structures) with an averaging criterion. The intelligent machine estimated the ischaemia and normal tissues with the average error of 2.91% for all the AVP doses and control cases.
 ...
PMID:Estimation of the tissue damage after MI through time-frequency analysis of the electromechanical signals. 2411 86

Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is one of the most common causes of hyponatremia. The usual causes are malignancies, central nervous system, pulmonary disorders, and drugs. Amiodarone is a broad spectrum antiarrhythmic agent widely used in the management of arrhythmias. The different side effects include thyroid dysfunction, visual disturbances, pulmonary infiltrates, ataxia, cardiac conduction abnormalities, drug interactions, corneal microdeposits, skin rashes, and gastrointestinal disturbances. SIADH is a rare but lethal side effect of amiodarone. We describe a 62-year-old male who was suffering from advanced prostatic malignancy, taking amiodarone for underlying heart disease. He developed SIADH which was initially thought to be paraneoplastic in etiology, but later histopathology refuted that. This case emphasizes the importance of detailed drug history and the role of immunohistochemistry in establishing the diagnosis and management of hyponatremia due to SIADH.
...
PMID:Amiodarone induced hyponatremia masquerading as syndrome of inappropriate antidiuretic hormone secretion by anaplastic carcinoma of prostate. 3042 Sep 33

Heart failure is a common problem in the ever growing population of patients with palliated congenital heart disease. It is frequently complicated by hyponatremia that has been associated with increased morbidity and mortality. Tolvaptan is a vasopressin receptor antagonist that has been effective in improving hyponatremia and congestive symptoms in adults with chronic heart failure. We describe the short-term use of tolvaptan to treat hyponatremic hypervolemia in an adolescent patient with chronic heart failure in the setting of palliated congenital heart disease prior to definitive surgical intervention. In this case, the patient had improvement in hyponatremia and a decrease in body weight, without any adverse effects.
 ...
PMID:Use of Tolvaptan in a Patient With Palliated Congenital Heart Disease. 2761 91

We report two cases of neonates with complex congenital heart disease and volume, catecholamine, and corticosteroid refractory shock treated with arginine-vasopressin. Arginine-vasopressin was able to reverse critical hypotension, but both patients developed severe hyponatremia, which recovered after discontinuation of arginine-vasopressin. Close control and prompt substitution of serum sodium is required in neonates with advanced heart failure on high-dose vasopressin therapy.
 ...
PMID:Severe Hyponatraemia Associated with the Use of Arginine-Vasopressin in Two Neonates with Complex Congenital Heart Disease. 3268 51


<< Previous 1 2 3